搜索筛选:
搜索耗时3.2542秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
类      型:
[会议论文] 作者:mingyue Wang,Suxia Luo, 来源:2019中国肿瘤学大会 年份:2019
Objective Esophageal squamous cell carcinoma(ESCC),a common gastrointestinal tumor,is listed as the sixth leading cause of cancer-related death worldwide,with high morbidity and mortality as its impor...
[期刊论文] 作者:Xiaobing Chen,Suxia Luo,Ning L, 来源:中德临床肿瘤学杂志:英文版 年份:2009
我们分析了的目的 cisplatin 的在 ERCC-1 (excisition 修理十字 complement-1 ) 的表示之间的关系, survivin 和敏感和预后包含了政体在先进的肺腺癌的首要的化疗。方法 Immu...
[期刊论文] 作者:Xiaobing Chen,Suxia Luo,Ning L, 来源:中德临床肿瘤学杂志(英文版) 年份:2004
Immunohistochemical (IHC) method was used to evaluate the expression of ERCC-1 and survivin in 80 pathologically confirmed advanced lung adenocarcinoma patients...
[会议论文] 作者:Xiao Qin Cao,Rufei Cao,Shuzheng Liu,Qiong Chen,Peiliang Quan,Suxia Luo, 来源:2019中国肿瘤学大会 年份:2019
Objective Objective: Liver cancer is the sixth most common cancer and the second leading cause of cancer deaths around the world.It is the third common cancer and the second leading cause of cancer de...
[期刊论文] 作者:Lin Zheng,Hailiang Li,Jinhua Huang,Jihoon Shin,Suxia Luo,Chenyang Guo,Yan Zhao,Fangkun Li, 来源:介入医学杂志(英文) 年份:2021
Objective:To explore the clinical significance of serum midkine(MDK) levels for the diagnosis of hepatocellular carcinoma(HCC) and evaluate the efficacy of inte...
相关搜索: